The Epstein Parton Foundation

The International Early Lung Cancer Action Program (I-ELCAP) is a prominent global initiative dedicated to the early diagnosis and treatment of lung cancer through an extensive screening program that began in 1992. With over 80 participating sites worldwide and led by Principal Investigator Claudia Henschke, the program has revolutionized lung cancer screening via low-dose CT scans, yielding a significant increase in the detection of early-stage lung cancers. I-ELCAP's mission is to disseminate innovative research and improve clinical care within a collaborative network, demonstrating exceptional success as evidenced by an estimated cure rate of up to 92% for Stage I lung cancers. Through continuous advancements, including the integration of artificial intelligence into the screening process, I-ELCAP strives to set the global standard for lung cancer screening and treatment. Generated from the website